{"name":"CRISPR Therapeutics","slug":"crispr-therapeutics","ticker":"","exchange":"","domain":"crispr.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"CTX131","genericName":"CTX131","slug":"ctx131","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"CTX131","genericName":"CTX131","slug":"ctx131","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiUkFVX3lxTFBCcTNHbThhaEJuTmlSaVZHQWRVYmhMUEdfWUpkRmowSkkybzhOV25HUjlfX1NtOVprODhma0NfdWgtb0tVYXRLNlFWS3plUDN4LUE?oc=5","date":"2026-04-07","type":"pipeline","source":"Yahoo Finance Singapore","summary":"CRISPR Therapeutics AG (CRSP) stock price, news, quote and history - Yahoo Finance Singapore","headline":"CRISPR Therapeutics AG (CRSP) stock price, news, quote and history","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxPSjN2bE1fTHVBQUFtQnozZG1HeTdzNzFyYW9ON0RjcERHOGM0TE13MTBSZFJqajF2RHJPTnVWcXJWc0ROX25rSWhpQ2s4WW9ZcXRHZF9QZzZKQkZqcEJZT2JrdUVyLWxRRW4tNEJTNXdFdnc4eWdGSjlVSm5DQ2xyWGNFYVNxMTh0MWFsSDlydXRxcm5hdGVRVDhPalhLLWZwZ3pDUlZn?oc=5","date":"2026-03-17","type":"deal","source":"The Motley Fool","summary":"Best CRISPR Companies to Buy in 2026 and How to Invest in Them - The Motley Fool","headline":"Best CRISPR Companies to Buy in 2026 and How to Invest in Them","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxQUWwwQkpPWXNiRUM2SjM3emo0aWZmUlBhMl9NcFd2V2pnT3VfLXhHRXd1cEJKS3h5Y3NmcFBCWE1CMS03bjA3ckZRS3NrMV9Wb1NDQ0RkRGFJYmI5V1hIMlNmb292bXI5WGwxSFUtTXNhQ2ZJQWtkVzZ2Z0hLbE1kbUJYMVVTeHk4Sk53c3V6N0RDdGFoZURNWDFZeTdGUXQzV3NlV2JzMzU5TVU?oc=5","date":"2026-03-09","type":"deal","source":"Seeking Alpha","summary":"Is A Vertex Buyout Of Crispr Therapeutics Inevitable? Here's My Take (NASDAQ:CRSP) - Seeking Alpha","headline":"Is A Vertex Buyout Of Crispr Therapeutics Inevitable? Here's My Take (NASDAQ:CRSP)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxNc1lCeEhrYjRRMUJwQmlRdVRrMnAyRWlwRnE1TWtxT0l4ODRjQ25sbHcwcVhVOGxMN2ZkR1I1ZkpEUWtac3JUd3pVb1pMM2VxMXhvM0JucnBWNU5GRndpM3MwRFFmWnBUdURfU0hoMlNCOW1iUVhpUnJWNjhiNmJnaXV5eXl3czN3cjhQR0hSVWl6QmNtdzRaQg?oc=5","date":"2026-03-04","type":"earnings","source":"The Motley Fool","summary":"Forget CRISPR Therapeutics: This Gene‑Editing Player Already Boasts the Profits It Dreams Of - The Motley Fool","headline":"Forget CRISPR Therapeutics: This Gene‑Editing Player Already Boasts the Profits It Dreams Of","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTFB1NWEzVGlyOHUyQldlZ1B3UEQzUkUtNWpIRUlkb2tsbm9zcjlaU1JIQ2NrUk9OY2w3eDdnendtbHo0cGNTSzZsalhXWXl4a01XN3UyY0FJMUM1Snl3VnFkeW5hRVJidzNsYTRmT2FOeGJCc1pMTldESnpLbmF5ZkE?oc=5","date":"2026-02-13","type":"earnings","source":"BioPharma Dive","summary":"Vertex’s CRISPR therapy rebounds in latest earnings - BioPharma Dive","headline":"Vertex’s CRISPR therapy rebounds in latest earnings","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxOQVhvaGZPcDFHU3c3NGJjQ0dQVmplZ0FFRGJneFcxekhfWlJSTUllN2hZTUdyaWR2OXpqNUdRV2FHUlNUSUlFZGNKOWZhckkyeWVRRldXVzhuT1RRRTkxWEFhNVhqMFo4OC1kMzZ3QWZnNGk0UkRLZzdQa1V1VURYMXl3YWxwTS03OTl2TUxvYlNuNlRCZVJwZGFGUkk0aUduaElZZERrOHRxR2FyWXNz?oc=5","date":"2026-02-13","type":"pipeline","source":"BioSpace","summary":"Vertex, CRISPR Set Lofty Goal for Casgevy Gene Therapy as Patient Starts Ramp - BioSpace","headline":"Vertex, CRISPR Set Lofty Goal for Casgevy Gene Therapy as Patient Starts Ramp","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizAFBVV95cUxNMnRwWlQyWkxUUWR0UXYyOUFkMDk0MU8xVmhYemRDWFJkQWpLSlgyNmoxcmRYMENHbFdZUkQ2VVlUc1VORmVYeEtwWEJ2NzRFa1Jrbm5oQXNUcldPbEVuUVpiTEc2T1RMRU1PYVR2N3VGSmNMOGJTaFZfMElQRmRyMEFxdVo3ZS0xaG11ZlJYY096eVExTHpuQUlyV3JlSmFKX1pmYVc1amxMV1pEcGxpYjdJNERnaWtaNVl5SHVmY25HWG1fS3BuVnNwS3U?oc=5","date":"2025-12-24","type":"pipeline","source":"The Globe and Mail","summary":"Is CRISPR Therapeutics Stock Yesterday's News? - The Globe and Mail","headline":"Is CRISPR Therapeutics Stock Yesterday's News?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxQcGJfWXZQVzVVMUNfZFRXOW1fRHZHUTlaVlFvTURmNWd6eEswMEdkSDlJMjd2U1pZc016eURvWDR2UnE4RWpQU0RFckNtd1FwMWVKMWFnVVo5aV9DOG9HdHliazNrVkkwelVEclRnTzFHQzBYX2VXbWJyYTZTdFFqMUxGV08zRlE?oc=5","date":"2025-12-19","type":"deal","source":"finviz.com","summary":"Is CRISPR Therapeutics a Buy, Sell, or Hold in 2026? - finviz.com","headline":"Is CRISPR Therapeutics a Buy, Sell, or Hold in 2026?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3AFBVV95cUxOWThkMTFHZl8tQWdvbG5ieUpBMHlYdVI1RVhSbmFFNmVTMlBxeWkxQ1VWVkRnR0ZZV2NQYnJIN29oTEU4ck1ubHRJbHpyT0c4UVF1UkV4S0s0UmV2Y183LWJNS2twNHNDY3RYYXBDUGJES0Vwb0s2UHRxSXlDV0ZDcXpXOWJNN0pyc0JudDF2Z0ZIT3RhMHNVOC1pcENwODFBdUozY1lqbzJ2Q0tpZHpfZVpvcTFHa3BfSGZPdHR6bUh3Z2xpSUpFWTgwQXhKcWFJVzdKZlROSExyZUNz?oc=5","date":"2025-12-06","type":"pipeline","source":"Reuters","summary":"Vertex's gene therapy shows promise in younger children with blood disorders - Reuters","headline":"Vertex's gene therapy shows promise in younger children with blood disorders","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxPa2ItUVA2YzZOSWN0WV85QmE3ZVhPLXZ0ZlRvR3JYMlNUcGpqbXNhYkk1cjBuMlVBenplRWp5OUxBY29ZMDZYQ2NCWHg4a0kta1RQcmFRVzlvSXVyTzkxNlVHZ181aWxmcFdpbE1BMEd0YUp4U0k1U3QzeEFKXy16cGR2aHMzaFR2ODVwTEhMTFQ2dDFUVC0yZQ?oc=5","date":"2025-12-06","type":"pipeline","source":"BioPharma Dive","summary":"Vertex CRISPR therapy hits early goal in children with blood disorders - BioPharma Dive","headline":"Vertex CRISPR therapy hits early goal in children with blood disorders","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAJBVV95cUxOSGZaM19GR05Hdy1yY3lTS1ZGMDY2UThXSWx2LVVhUWh0N2xYTnYwdXNFU0wxRHo3alQ1T1hDZWdYZWZsbVliSXM1YXNzekprTEZPcnF3U3lYUS1aYzYwdlZ0SEprLWlFWE5vb3poZVo0ZWJnOW4zWmJHcWZYYmRyX05KdS05S0liUjJ6dGcyenBrNktkdWtWZS1BbUd1VGVNb21CYWpPWk9qc0JScHVrUzNPN1hZbVlzUUpycmxyWWtoWHc1ZDZCSU1mN1k3RExjM3BQdUthOFNiQTRxYUVVZzBLSUY1S2toR05uSjQ1U0NNVGNxNXM5WkN1cldVTWZ2dDJ3S2lOYWs3bzJHNU9lVDBWYXBzU0tF?oc=5","date":"2025-10-02","type":"trial","source":"GlobeNewswire","summary":"CRISPR Therapies Clinical Trial Pipeline Shows Potential - GlobeNewswire","headline":"CRISPR Therapies Clinical Trial Pipeline Shows Potential","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZkFVX3lxTFBVQS1YTU1aUTdrRDdfaDk1eTc1RkZObE1IZWE2NUdBX3NzYzF2ejVkNmR5NThLX2VRa2NPVFJXcEN2TTZlZ0pucUxPTE5fVllfUW1wcW82czlRWVc2ZGduX1RtZDhXUQ?oc=5","date":"2025-09-30","type":"pipeline","source":"Labiotech.eu","summary":"CRISPR technology’s next wave: Ten companies to watch in 2025 - Labiotech.eu","headline":"CRISPR technology’s next wave: Ten companies to watch in 2025","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}